Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS

被引:46
作者
Sgagias, MK
Wagner, KU
Hamik, B
Stoeger, S
Spieker, R
Huber, LJ
Chodosh, LA
Cowan, KH
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[2] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
Bcra1-deficiency; DNA-damage and repair; breast cancer; CDDP; MMS;
D O I
10.4161/cc.3.11.1211
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this report we describe the isolation of an isogenic pair of Brca1(++) and Brca1(-/-) murine mammary epithelial cells (MMECs). These cells were isolated from Brca1 conditional knock-out mice which contained loxP sites flanking exon 11 of the Brca1 gene (Brca1(f1/f1)) and then immortalized by infection with HPV-16E6 retrovirus to degrade p53 protein. Brca1-/- MMECs were generated by deletion of exon 11 following transduction of Brca1(f1/f1) MMECs with a retroviral vector expressing Cre recombinase. Brca1-deficiency rendered MMECs sensitive to cis-platinum (II) diamine dichloride ( CDDP) and methylmethane sulfonate (MMS). The Brca1(+/+) and Brca1(-/-) MMECs is the only known pair of isogenic mammary epithelial cell lines. The understanding of the mechanisms of the CDDP sensitivity of the BRCA1-deficient mammary epithelial cells would be very important in understanding how BRCA1-deficiency plays a role in tissue specific breast cancer chemotherapy. These studies support the role of BRCA1 in the CDDP-induced and MMS-induced DNA damage and repair by p53-independent pathways.
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 48 条
[1]   BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair [J].
Abbott, DW ;
Thompson, ME ;
Robinson-Benion, C ;
Tomlinson, G ;
Jensen, RA ;
Holt, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18808-18812
[2]   MOUSE BRCA1 - LOCALIZATION, SEQUENCE-ANALYSIS AND IDENTIFICATION OF EVOLUTIONARILY CONSERVED DOMAINS [J].
ABEL, KJ ;
XU, JZ ;
YIN, GY ;
LYONS, RH ;
MEISLER, MH ;
WEBER, BL .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2265-2273
[3]  
Aida H, 1998, CLIN CANCER RES, V4, P235
[4]   A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Stratton, MR ;
Peto, J ;
Ponder, BJ ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83
[5]   Sequence analysis of the rat Brca1 homolog and its promoter region [J].
Bennett, LM ;
Brownlee, HA ;
Hagavik, S ;
Wiseman, RW .
MAMMALIAN GENOME, 1999, 10 (01) :19-25
[6]   The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin [J].
Bhattacharyya, A ;
Ear, US ;
Koller, BH ;
Weichselbaum, RR ;
Bishop, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23899-23903
[7]   Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism [J].
Cavalieri, EL ;
Rogan, EG ;
Chakravarti, D .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (04) :665-681
[8]  
Chandler J, 2001, GENESIS, V29, P72, DOI 10.1002/1526-968X(200102)29:2<72::AID-GENE1007>3.0.CO
[9]  
2-B
[10]   Relationship between base excision repair capacity and DNA alkylating agent sensitivity in mouse monocytes [J].
Chen, KH ;
Srivastava, DK ;
Wilson, SH .
MUTATION RESEARCH-DNA REPAIR, 2001, 487 (3-4) :121-126